Jeankumar, V., Renuka, J., Kotagiri, S., Saxena, S., Kakan, S., Sridevi, J., … Sriram, D. (2014). Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues. ChemMedChem, 9(8), 1850-9. https://doi.org/10.1002/cmdc.201402035

Krátký, M., Novotná, E., Saxena, S., Yogeeswari, P., Sriram, D., Švarcová, M., & Vinšová, J. Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes. TheScientificWorldJournal, 2014, 703053. https://doi.org/10.1155/2014/703053 (Original work published 2014)

Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)

Saxena, S., Renuka, J., Jeankumar, V., Yogeeswari, P., & Sriram, D. Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies. Current Topics in Medicinal Chemistry, 14(17), 1990-2005. Retrieved from http://www.eurekaselect.com/124977/article (Original work published 2014)

Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)

Saxena, S., Renuka, J., Yogeeswari, P., & Sriram, D. (2014). Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation. Molecular Informatics, 33(9), 597-609. https://doi.org/10.1002/minf.201400058

Devi, P., Samala, G., Sridevi, J., Saxena, S., Alvala, M., Salina, E., … Yogeeswari, P. (2014). Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. ChemMedChem, 9(11), 2538-47. https://doi.org/10.1002/cmdc.201402171

Poyraz, O., Jeankumar, V., Saxena, S., Schnell, R., Haraldsson, M., Yogeeswari, P., … Schneider, G. (2013). Structure-guided design of novel thiazolidine inhibitors of O-acetyl serine sulfhydrylase from Mycobacterium tuberculosis. Journal of Medicinal Chemistry, 56(16), 6457-66. https://doi.org/10.1021/jm400710k (Original work published 2013)

Saxena, S., Devi, P., , Yogeeswari, P., & Sriram, D. (2014). Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening. Journal of Molecular Graphics & Modelling, 47, 37-43. https://doi.org/10.1016/j.jmgm.2013.08.005

Samala, G., Devi, P., Nallangi, R., Sridevi, J., Saxena, S., Yogeeswari, P., & Sriram, D. (2014). Development of novel tetrahydrothieno 2,3-c pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads. Bioorganic & Medicinal Chemistry, 22(6), 1938-47. https://doi.org/10.1016/j.bmc.2014.01.030 (Original work published 2014)